Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:20 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 506365 | NSE: CHEMOPH

Chemo Pharma Laboratories Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹4.08Overvalued by 96.48%vs CMP ₹116.00

P/E (15.0) × ROE (3.5%) × BV (₹9.60) × DY (2.00%)

Defaults: P/E=15

₹12.64Overvalued by 89.10%vs CMP ₹116.00
MoS: -817.7% (Negative)Confidence: 58/100 (Moderate)Models: All 5: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹1.6729%Over (-98.6%)
Graham NumberEarnings₹22.1426%Over (-80.9%)
Earnings PowerEarnings₹9.2617%Over (-92%)
Net Asset ValueAssets₹13.3317%Over (-88.5%)
Earnings YieldEarnings₹22.7011%Over (-80.4%)
Consensus (5 models)₹12.64100%Overvalued
Key Drivers: EPS CAGR -58.9% drags value — could be higher if earnings stabilize. | ROE 3.5% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -58.9% · Defaults: P/E=15

*Investments are subject to market risks

Investment Snapshot

41
Chemo Pharma Laboratories Ltd scores 41/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health38/100 · Weak
ROCE 5.2% WeakROE 3.5% WeakD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent
Smart Money50/100 · Moderate
Promoter holding at 27.9% Stable
Earnings Quality50/100 · Moderate
OPM stable around 0% Steady
Quarterly Momentum40/100 · Moderate
Profit (4Q): -3,135% YoY Declining
Industry Rank30/100 · Weak
ROCE 5.2% vs industry 16.4% Below peersROE 3.5% vs industry 15.2% Below peers

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:20 am

Market Cap 17.4 Cr.
Current Price 116
Intrinsic Value₹12.64
High / Low 153/75.0
Stock P/E
Book Value 9.60
Dividend Yield0.00 %
ROCE5.17 %
ROE3.47 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Chemo Pharma Laboratories Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Lactose (India) Ltd 106 Cr. 84.2 137/76.021.9 49.60.00 %12.9 %9.69 % 10.0
MPS Pharmaa Ltd 3.15 Cr. 1.65 3.17/1.57 0.330.00 %9.79 %59.0 % 10.0
Gujarat Themis Biosyn Ltd 2,692 Cr. 247 479/22256.3 24.30.27 %27.3 %21.7 % 1.00
Gujarat Terce Laboratories Ltd 25.3 Cr. 32.5 68.4/29.0 10.10.00 %41.4 %14.6 % 10.0
Gujarat Inject (Kerala) Ltd 120 Cr. 82.1 82.1/17.0481 6.930.00 %13.5 %11.0 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Chemo Pharma Laboratories Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 0.000.000.000.000.000.000.000.000.000.000.000.530.00
Expenses 0.020.020.050.020.020.100.050.020.020.0211.830.430.09
Operating Profit -0.02-0.02-0.05-0.02-0.02-0.10-0.05-0.02-0.02-0.02-11.830.10-0.09
OPM % 18.87%
Other Income 0.19-0.100.430.460.700.250.300.63-0.15-0.160.020.000.00
Interest 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation 0.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax 0.17-0.120.380.440.680.150.250.61-0.17-0.18-11.810.10-0.09
Tax % 0.00%25.00%0.00%0.00%0.00%293.33%0.00%0.00%0.00%88.89%0.00%0.00%0.00%
Net Profit 0.16-0.150.380.440.68-0.290.250.61-0.17-0.34-11.810.10-0.09
EPS in Rs 1.07-1.002.532.934.53-1.931.674.07-1.13-2.27-78.730.67-0.60

Last Updated: March 3, 2026, 11:26 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 2:20 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 0000000000001
Expenses 00000100000012
Operating Profit -0-0-0-0-0-1-0-0-0-0-0-0-12
OPM % -2,234%
Other Income 000611111021-0
Interest 0000000000000
Depreciation 0000000000000
Profit before tax 000510000020-12
Tax % 19%26%31%12%86%19%16%19%-56%38%27%33%
Net Profit 000500001010-12
EPS in Rs 1.601.871.4731.200.671.402.801.673.730.338.002.27-80.93
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182022-20232024-2025
YoY Net Profit Growth (%)-100.00%-100.00%-100.00%
Change in YoY Net Profit Growth (%)0.00%0.00%0.00%

Chemo Pharma Laboratories Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 3 years from 2017-2018 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:%
Compounded Profit Growth
10 Years:2%
5 Years:-4%
3 Years:-4%
TTM:-1184%
Stock Price CAGR
10 Years:18%
5 Years:64%
3 Years:54%
1 Year:65%
Return on Equity
10 Years:3%
5 Years:4%
3 Years:4%
Last Year:3%

Last Updated: September 5, 2025, 2:56 pm

Balance Sheet

Last Updated: December 10, 2025, 4:03 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 2222222222222
Reserves 3449999910101112-0
Borrowings 0000000000000
Other Liabilities 0001000000001
Total Liabilities 5661110101111121213132
Fixed Assets 0000000000000
CWIP 0000000000000
Investments 2220000033400
Other Assets 4441110101111999132
Total Assets 5661110101111121213132

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -0-0-06-2-55-0-0-11-0
Cash from Investing Activity + 0001111-011-110
Cash from Financing Activity + 000-01002-2-0-0-0
Net Cash Flow -00061-561-1-0010
Free Cash Flow -0-0-06-2-55-0-0-11-0
CFO/OP 92%-25%206%-2,615%294%970%-1,023%94%66%335%-468%67%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow0.000.000.000.000.00-1.000.000.000.000.000.000.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %7%8%6%4%8%3%5%3%1%1%13%5%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 27.88%27.88%27.88%27.88%27.88%27.88%27.88%27.88%27.88%27.88%27.89%27.89%
DIIs 0.17%0.17%0.17%0.17%0.17%0.17%0.17%0.37%0.37%0.17%0.17%0.37%
Government 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.20%0.20%0.00%
Public 71.95%71.95%71.95%71.95%71.94%71.95%71.95%71.75%71.75%71.74%71.75%71.74%
No. of Shareholders 6,2896,2686,2756,2546,2626,2546,3826,5766,5106,4226,4096,360

Shareholding Pattern Chart

No. of Shareholders

Chemo Pharma Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 16
FaceValue 10.00
Basic EPS (Rs.) -9.66
Diluted EPS (Rs.) -9.66
Cash EPS (Rs.) -9.66
Book Value[Excl.RevalReserv]/Share (Rs.) 24.49
Book Value[Incl.RevalReserv]/Share (Rs.) 24.49
PBDIT / Share (Rs.) -8.98
PBIT / Share (Rs.) -8.98
PBT / Share (Rs.) -8.98
Net Profit / Share (Rs.) -9.66
NP After MI And SOA / Share (Rs.) -9.66
Return on Networth / Equity (%) -39.44
Return on Capital Employeed (%) -35.51
Return On Assets (%) -37.44
Current Ratio (X) 28.82
Quick Ratio (X) 28.82
Enterprise Value (Cr.) 2.24
EV / EBITDA (X) -1.66
Price / BV (X) 0.72
EarningsYield -0.54

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Chemo Pharma Laboratories Ltd. is a Public Limited Listed company incorporated on 17/08/1942 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1942PLC003556 and registration number is 003556. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 1.50 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Pharmaceuticals5, Kumud Apartment CHS Ltd., Thane District Maharashtra 421301chemopharmalab@gmail.com
http://www.thechemopharmalaboratoriesltd.com
Management
NamePosition Held
Mr. Bhavin ShethExecutive Director & CEO
Mr. Ashok SomaniExecutive Director & CFO
Mrs. Shanta SomaniNon Executive Director
Mr. Mathura Prasad SharmaIndependent Director
Mr. Toby AntonyIndependent Director
Mr. Nandkumar PareekIndependent Director

FAQ

What is the intrinsic value of Chemo Pharma Laboratories Ltd and is it undervalued?

As of 10 April 2026, Chemo Pharma Laboratories Ltd's intrinsic value is ₹12.64, which is 89.10% lower than the current market price of ₹116.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (3.47 %), book value (₹9.60), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Chemo Pharma Laboratories Ltd?

Chemo Pharma Laboratories Ltd is trading at ₹116.00 as of 10 April 2026, with a FY2026-2027 high of ₹153 and low of ₹75.0. The stock is currently in the middle of its 52-week range. Market cap stands at ₹17.4 Cr..

How does Chemo Pharma Laboratories Ltd's P/E ratio compare to its industry?

Chemo Pharma Laboratories Ltd has a P/E ratio of , which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Chemo Pharma Laboratories Ltd financially healthy?

Key indicators for Chemo Pharma Laboratories Ltd: ROCE of 5.17 % is on the lower side compared to the industry average of 16.35%; ROE of 3.47 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Chemo Pharma Laboratories Ltd profitable and how is the profit trend?

Chemo Pharma Laboratories Ltd reported a net profit of ₹0 Cr in Mar 2025. Compared to ₹1 Cr in Mar 2022, the net profit shows a declining trend.

Does Chemo Pharma Laboratories Ltd pay dividends?

Chemo Pharma Laboratories Ltd has a dividend yield of 0.00 % at the current price of ₹116.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Chemo Pharma Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports